Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (359)
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
10,000
Price
$6.92
Total Value
$69.17K
Shares Held After
600,887
% of Holdings
1.6%
SOPHiA GENETICS SA (SOPH)
Verma Abhimanyu — Chief Technology Officer
Shares
5,000
Price
$6.95
Total Value
$34.77K
Shares Held After
187,171
% of Holdings
2.6%
HEALTHCARE SERVICES GROUP INC (HCSG)
Kush Andrew — EVP&Chief Operating Officer
Shares
15,598
Price
$23.24
Total Value
$362.50K
Shares Held After
22,741
% of Holdings
40.7%
Anika Therapeutics, Inc. (ANIK)
Fischetti Gary P — Director
Shares
1,000
Price
$20.32
Total Value
$20.32K
Shares Held After
54,015
% of Holdings
1.9%
BOSTON SCIENTIFIC CORP (BSX)
Habiger David C — Director
Shares
140
Price
$48.59
Total Value
$6.80K
Shares Held After
15,060
% of Holdings
0.9%
SHOULDER INNOVATIONS, INC. (SI)
Gilde Healthcare Holding B.V. — 10% Owner
Shares
99,812
Price
$22.77
Total Value
$2.27M
Shares Held After
2,221,640
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
299
Price
$520.49
Total Value
$155.63K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
517
Price
$519.50
Total Value
$268.58K
Shares Held After
324,742
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,446
Price
$518.40
Total Value
$749.60K
Shares Held After
325,259
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,142
Price
$517.50
Total Value
$1.63M
Shares Held After
326,705
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,456
Price
$516.59
Total Value
$1.27M
Shares Held After
329,847
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
605
Price
$515.50
Total Value
$311.88K
Shares Held After
332,303
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
675
Price
$514.43
Total Value
$347.24K
Shares Held After
332,908
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
182
Price
$513.39
Total Value
$93.44K
Shares Held After
333,583
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
178
Price
$512.49
Total Value
$91.22K
Shares Held After
333,765
% of Holdings
0.1%
FATE THERAPEUTICS INC (FATE)
TAHL CINDY — Chief Legal and Compliance Officer
Shares
38,800
Price
$2.46
Total Value
$95.41K
Shares Held After
589,355
% of Holdings
6.2%
Korro Bio, Inc. (KRRO)
Aiyar Ram — Director
Shares
5,802
Price
$10.84
Total Value
$62.92K
Shares Held After
69,046
% of Holdings
7.8%
Evogene Ltd. (EVGN)
RECANATI LEON — Director
Shares
800,000
Price
$0.50
Total Value
$400.00K
Shares Held After
883,886
% of Holdings
90.5%
MERIT MEDICAL SYSTEMS INC (MMSI)
Peterson Neil W. — CHIEF OPERATING OFFICER
Shares
21,449
Price
$85.00
Total Value
$1.82M
Shares Held After
25,551
% of Holdings
45.6%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
2,611
Price
$24.64
Total Value
$64.34K
Shares Held After
117,227
% of Holdings
2.2%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
1,500
Price
$23.87
Total Value
$35.80K
Shares Held After
119,838
% of Holdings
1.2%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
2,967
Price
$24.65
Total Value
$73.13K
Shares Held After
40,166
% of Holdings
6.9%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
1,794
Price
$23.89
Total Value
$42.86K
Shares Held After
43,133
% of Holdings
4.0%
GENELUX Corp (GNLX)
Yu Yong — Chief Scientific Officer
Shares
653
Price
$2.94
Total Value
$1.92K
Shares Held After
268,371
% of Holdings
0.2%
GENELUX Corp (GNLX)
Cappello Joseph — Chief Technical Officer
Shares
653
Price
$2.95
Total Value
$1.92K
Shares Held After
328,737
% of Holdings
0.2%
GENELUX Corp (GNLX)
Zindrick Thomas — President and CEO
Shares
3,023
Price
$2.95
Total Value
$8.91K
Shares Held After
1,260,890
% of Holdings
0.2%
Jushi Holdings Inc. (JUSH)
Barack Louis Jon — President
Shares
10,000
Price
$0.43
Total Value
$4.30K
Shares Held After
2,883,773
% of Holdings
0.3%
Tilray Brands, Inc. (TLRY)
Merton Carl A — Chief Financial Officer
Shares
10,000
Price
$4.62
Total Value
$46.20K
Shares Held After
139,753
% of Holdings
7.2%
BIOGEN INC. (BIIB)
Minor Lloyd — Director
Shares
593
Price
$203.34
Total Value
$120.58K
Shares Held After
3,282
% of Holdings
15.3%
Arcutis Biotherapeutics, Inc. (ARQT)
Watanabe Todd — Director
Shares
4,375
Price
$26.12
Total Value
$114.26K
Shares Held After
717,203
% of Holdings
0.6%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
955
Price
$26.12
Total Value
$24.94K
Shares Held After
119,289
% of Holdings
0.8%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
1,230
Price
$26.12
Total Value
$32.12K
Shares Held After
126,171
% of Holdings
1.0%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
100
Price
$97.10
Total Value
$9.71K
Shares Held After
97,994
% of Holdings
0.1%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,300
Price
$96.30
Total Value
$221.49K
Shares Held After
98,094
% of Holdings
2.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
5,100
Price
$95.21
Total Value
$485.57K
Shares Held After
100,394
% of Holdings
4.8%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
16
Price
$97.46
Total Value
$1.56K
Shares Held After
567,540
% of Holdings
0.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
1,392
Price
$96.82
Total Value
$134.77K
Shares Held After
567,556
% of Holdings
0.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
5,635
Price
$95.93
Total Value
$540.57K
Shares Held After
568,948
% of Holdings
1.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
7,157
Price
$95.10
Total Value
$680.63K
Shares Held After
574,583
% of Holdings
1.2%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
800
Price
$93.97
Total Value
$75.18K
Shares Held After
581,740
% of Holdings
0.1%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
334
Price
$267.99
Total Value
$89.51K
Shares Held After
170,073
% of Holdings
0.2%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
317
Price
$267.99
Total Value
$84.95K
Shares Held After
52,115
% of Holdings
0.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
109
Price
$267.99
Total Value
$29.21K
Shares Held After
245,614
% of Holdings
0.0%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
731
Price
$267.99
Total Value
$195.90K
Shares Held After
2,275,394
% of Holdings
0.0%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
128
Price
$268.70
Total Value
$34.39K
Shares Held After
129,019
% of Holdings
0.1%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
1,233
Price
$267.79
Total Value
$330.18K
Shares Held After
129,147
% of Holdings
0.9%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
192
Price
$265.27
Total Value
$50.93K
Shares Held After
130,380
% of Holdings
0.1%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
947
Price
$263.94
Total Value
$249.95K
Shares Held After
130,572
% of Holdings
0.7%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
200
Price
$261.49
Total Value
$52.30K
Shares Held After
131,519
% of Holdings
0.2%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
300
Price
$259.98
Total Value
$77.99K
Shares Held After
131,719
% of Holdings
0.2%
Showing 101–150 of 359 transactions (page 3 of 8)